Scythian Biosciences Corp (SCYB.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2019 | 09-2018 | 09-2017 | 09-2016 | 09-2015 | |
| Operating Expenses | 6,290 | 8,104 | 3,880 | 1,755 | 2,092 |
| Operating Income | -6,290 | -8,104 | -3,880 | -1,755 | -2,092 |
| Interest Expense | 75 | N/A | N/A | N/A | N/A |
| Other Income | -1,726 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -8,091 | -8,104 | -3,880 | -1,755 | -2,092 |
| Net Income Continuous | -8,091 | -8,104 | -3,880 | -1,755 | -2,092 |
| Minority Interests | 71 | N/A | N/A | N/A | N/A |
| Net Income | $-8,020 | $-8,104 | $-3,880 | $-1,755 | $-2,092 |
| EPS Basic Total Ops | -0.70 | -0.90 | -0.60 | -0.30 | -0.50 |
| EPS Basic Continuous Ops | -0.70 | -0.90 | -0.60 | -0.30 | -0.50 |
| EPS Diluted Total Ops | -0.70 | -0.90 | -0.60 | -0.30 | -0.50 |
| EPS Diluted Continuous Ops | -0.70 | -0.90 | -0.60 | -0.30 | -0.50 |
| EBITDA(a) | $-6,839 | $-7,194 | $-3,227 | $-1,102 | $-1,758 |